Startups

AI-based platform for clinical trials.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 60

Locations

Company Size

  • 1 - 11

Last Stage Round

Insights

Klineo, based in Paris, is an AI-powered platform aimed at revolutionizing clinical trials through automation and optimization. Its B2B SaaS model addresses significant industry pain points like manual data entry, traditional monitoring methods, and inefficient software. By leveraging AI, Klineo seeks to accelerate trial completion times, reduce costs, and minimize errors, offering a substantial competitive edge. Supported by investors such as Pfizer Healthcare Hub: London, Bpifrance, and Wilco, Klineo is well-positioned to capture significant market share and drive innovation in clinical trials.

Total Funding
$2.1M

Full Company Profile